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Fas Is Required for Clonal Selection
in Germinal Centers and the Subsequent
Establishment of the Memory B Cell Repertoire
controlled, at least in part, by several antiapoptotic and
proapoptotic molecules. Transgenic mice overexpress-
ing Bcl-xL and Bcl-2 show an accumulation of low-affin-
ity or autoreactive B cells in either the long-lived AFC
or the memory compartment, indicating that those types
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Tokyo 162-8640 of B cells are purged by apoptosis in normal mice (Hande
et al., 1998; Takahashi et al., 1999; Smith et al., 2000).Japan
Fas (CD95) is a member of the tumor necrosis factor
receptor family, and binding of the ligand, Fas-L, to Fas
triggers apoptosis in many types of cells (Nagata andSummary
Golstein, 1995). Failure of this process by the mutation of
Fas (lpr mutation) results in lymphoproliferative disease,In T cell–dependent immune responses, high-affinity B
cells are selected and differentiate into memory cells; including the emergence of oligoclonally expanded, au-
toreactive B cells bearing somatically mutated IgGshowever, the mechanism behind this process remains
largely unknown. Here, we report that the selection of (Shlomchik et al., 1987; Watanabe-Fukunaga et al.,
1992). Fas is expressed in GC B cells that are highlyhigh-affinity B cells within germinal centers (GCs) is
impaired in Fas-deficient lpr mice in the primary re- susceptible to Fas-mediated apoptosis in vitro (Liu et
al., 1995; Smith et al., 1995), raising the idea that Fassponse, probably owing to inefficient negative selec-
tion. The memory compartment in control mice is is involved in the negative selection within the GCs.
However, GC and memory B cells as well as high-affinitymostly established by precursors generated from the
early GCs, whereas the lpr defect expands the memory antibody-forming cells (AFCs) were normally generated
in lpr/lpr mice during the primary response to thecompartment by the increased recruitment of newly
generated precursors from the late GCs, resulting in (4-hydroxy-3-nitrophenyl)acetyl (NP) hapten, leading to
the conclusion that Fas is not involved in regulation ofthe accumulation of heavily mutated memory B cells
at high frequency. These results suggest that Fas is the B cell response to antigen (Smith et al., 1995).
In the present study, by virtue of a flow-cytometricrequired for clonal selection within GCs and the estab-
lishment of the memory B cell repertoire. technique discriminating memory B cells from GC B
cells, we have analyzed the dynamics of GC and memory
B cells and their accumulation of somatic mutations inIntroduction
lpr/lpr mice and wild-type control mice after immuniza-
tion with NP hapten coupled to chicken g globulin (NP-In response to T cell–dependent antigens, B cells are
activated by interaction with T cells and form GCs (Liu CG). Our data suggest that the lpr mutation affects clonal
selection within GCs and accelerates the accumulationet al., 1991; Kelsoe, 1996). GCs peak in number 2 weeks
after immunization and then rapidly decline to the basal of heavily mutated B cells in the memory compartment.
Thus, the present study supports the notion that Fas-level by day 30 (Liu et al., 1991; Takahashi et al., 1998).
Long-lived AFCs and memory B cells are generated mediated apoptosis may control clonal selection and
the following recruitment into the memory compartment.within GCs around 1–2 weeks after immunization and
persist largely without proliferation (Schittek and Rajew-
sky, 1990; Gray et al., 1994; Manz et al., 1997; Smith et Results
al. 1997; Slifka et al., 1998). The populations are resistant
to chronic treatment with either anti-CD4 or anti-CD154 Functional Memory B Cells Are Enriched
(CD40 ligand) Abs once established (Vieira and Rajew- in a IgG1high/CD381 Population
sky, 1990; Takahashi et al., 1998). Thus, it is postulated As shown in Figure 1A, C57BL/6 mice were immunized
that both populations are maintained without further with alum-precipitated NP-CG, and NP-specific B cells
replenishment by the newly generated precursors from were monitored using flow-cytometry with hapten
the GCs. GC B cells accumulate somatic mutations (Be- (4-hydroxy-5-iodo-3-nitrophenyl)acetyl (NIP) coupled to
rek et al., 1991; Jacob et al., 1991), which increases BSA, because anti-NP antibodies bind the cross-
antibody affinity for eliciting antigen, but it may also reacting hapten NIP with higher affinity than the homolo-
change antibody specificity, sometimes resulting in the gous hapten NP (Imanishi and Ma¨kela¨, 1973). To purify
acquisition of autoreactivity (Hande et al., 1998). The GC and memory B cells, AFCs with phenotype
subsequent clonal selection allows a selective accumu- B220dullCD431 (Gulley et al., 1988; Smith et al., 1996),
lation of high-affinity variants through two steps of se- naive B cells, B-1 cells, and T cells were excluded from
lection: active loss of low-affinity or autoreactive ones splenocytes by a MACS system with use of biotinylated
(negative selection) and preferential retention of higher- mAbs against m, d, CD5, CD90, and CD43. As shown in
affinity ones (positive selection) (Kelsoe, 1996; Pulen- Figure 1A, dead cells and residual IgM1IgD1CD51
dran et al., 1997). The process of negative selection is CD431CD901 cells were excluded from the negatively
separated cells by gating (a) and B2201 cells were se-
lected under the lymphocyte gate (a and b).* To whom correspondence should be addressed (e-mail: ttoshi@
nih.go.jp). As previously reported (Oliver et al., 1997), more than
Immunity
182
Figure 1. Characterization of NP Binding B Cell Subpopulations
(A) The sorting strategy for NP-specific B cell subpopulations. Splenocytes were recovered from NP-CG-primed C57BL/6 mice at day 60
postimmunization and incubated with biotinylated mAbs against (IgM, IgD, CD90, CD43, and CD5). The cells recognized by the biotinylated
mAbs were depleted by MACS first, and then residual cells and dead cells were excluded by gating after staining with anti-B220TX, anti-
CD38APC, anti-IgG1FITC mAbs and with NIP-BSAPE, followed by incubation with streptavidineTC (TC) and 7-AAD (a, R1). Viable B2201 cells were
then selected under a lymphocyte gate on forward with side light scatter (b, R2). Thereafter, NIP binding/B2201 cells were gated (c and d,
R3) and then separated into IgG1high/CD381 and IgG1dull/CD38dull cells, respectively (e, f, and g). NIP binding/B2201 cells were also detected
in the IgG12/CD381 cells (e, f, and g). The results in d and g show the staining patterns of the NIP binding B cells (d) and their subpopulations
(g) in the splenocytes of nonimmunized mice after negative selection with a MACS system for cell sorting. The staining patterns of NIP binding
B cell subpopulations in the splenocytes of the immunized lpr mice after negative selection is shown in f. The number of gated cells per
collection of 1,000,000 events is listed on each panel.
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90% of NIP binding/B2201/CD38dull cells in the spleens
of immunized C57BL/6 mice bound high levels of peanut
aggulutinin (PNA) (data not shown), suggesting that GC
B cells were highly enriched in the CD38dull B cell popula-
tion. Because CD38 could be utilized as a discriminating
marker for GC and memory B cells (Ridderstadt and
Tarlinton, 1998) and IgG11 B cells dominate the GC in
response to NP (data not shown), we characterized and
sorted NIP binding B cells that express high levels of
IgG1 and CD38 (IgG1high/CD381) and low levels of IgG1
and CD38 (IgG1dull/CD38dull), as memory cells and GC B
cells, respectively (Figure 1A). These cells were highly
enriched in the splenocytes of the immunized mice after
the sorting process (Figures 1Ac and 1Ae) but unde-
tectable in the nonimmunized mice (Figures 1Ad and Figure 2. Reconstitution of the Memory Response by an Adoptive
1Ag). ELISPOT analysis showed that antibody-secreting Transfer of IgG1high/CD381 Populations
cells were barely detected (,0.1%) in the purified IgG1high/ NIP binding B cells with an IgG1high/CD381 or IgG1dull/CD38dull pheno-
type were purified from the pooled spleens (n 5 8) of NP-CG-primedCD381 and IgG1dull/CD38dull B cell fractions, analyzed at
C57BL/6 mice at day 60 postimmunization. The purified cells (2 3days 8, 20, and 60 postimmunization (data not shown).
103) were transferred into nonirradiated C57BL/6 mice, which hadGiemsa staining showed that NIP binding/B2201/
been immunized with CG 30 days before. As a control, mice were
IgG1high/CD381 cells often exhibited the membrane pro- injected with 1 3 107 of naive splenocytes (–). Each recipient mouse
cess at a different degree in size and number (Figure was i.v. immunized with 50 mg of soluble NP-CG 1 hr later. Ten days
1Bb), in agreement with the previous observation in hu- later, the amounts of NP2 binding IgG1 serum antibodies (A) and
the numbers of NP2 binding IgG1 BM AFCs (B) were determinedman memory B cells (Liu et al., 1995). These cells were
as either high-affinity anti-NP antibodies or AFCs by ELISA andsmaller than the NIP binding GC B cells, which had large
ELISPOT, respectively. Each circle represents the results for individ-nuclei and basophilic cytoplasm (Figure 1Ba), but larger
ual mice. The data are representative of three independent experi-
than the naive IgD1 B cells (Figure 1Bc). Semiquantita- ments.
tive RT-PCR (Figure 1C) showed that the NIP binding
GC B cells (G) expressed mRNA for Bcl-xL, Bcl-6, and
Fas, to a greater extent than found in other B cell sub- tively (Figure 1D). The frequency of IgG1dull/CD38dull cells
rapidly declined at day 20 and finally reached valuespopulations, as expected from the previous reports (Cat-
toretti et al., 1995; Smith et al., 1995; Takahashi et al., z10 times above the level of nonimmunized mice at day
80 postimmunization, whereas the frequency of IgG1high/1999). NIP binding/B2201/IgG1high/CD381 cells (M) ex-
pressed mRNA for Bcl-2 and Fas, at a low level, whereas CD381 cells remained constant from day 20 to day 80
following immunization.naive B cells (N) expressed Bcl-2, but not Fas. Consis-
tently, B2201/IgG1high/CD381 cells, but not IgD1 B cells, To confirm that NIP binding/B2201/IgG1high/CD381
cells represent memory cells, NIP binding B cells withexpressed Fas on the surface, albeit at a level 5–10
times below that found in GC B cells (data not shown). the phenotype of IgG1high/CD381 and IgG1dull/CD38dull
were purified from the pooled spleens of C57BL/6 miceThese results suggest that NIP binding/B2201/IgG1high/
CD381 cells are phenotypically different from naive and immunized with NP-CG 60 days before (Figure 2). The
purified cells were then intravenously injected into CG-GC B cells.
We observed that the frequency of NIP binding B cells primed C57BL/6 mice at a dosage of 2000 cells per
recipient mouse, together with 1 3 107 naive spleno-with phenotype IgG1high/CD381 and IgG1dull/CD38dull was
significantly increased at the peak response, z70- and cytes. As a control, a group of mice was given an injec-
tion of 1 3 107 naive splenocytes. Ten days after boost-3000-fold compared to nonimmunized mice, respec-
(B) Morphological characterization of B cell subpopulations by Giemsa staining (original magnifcation, 100 3 10). NIP binding/B2201/IgG1dull/
CD38dull cells (a and d), NIP binding/B2201/IgG1high/CD381 cells (b and e), and IgD1B2201 cells (c and f) were purified from the spleens of
C57BL/6 mice (a, b, and c) and C57BL/6-lpr/lpr mice (d, e, and f) at day 60 postimmunization. In a box in b and e, the morphology of the cells
with the distinctive processes is shown. A representative result from more than two independent sorting experiments is shown in each upper
and lower panel.
(C) The expression of Fas and Bcl-2-related mRNA in memory and GC B cells. IgD1B2201 (N), NIP binding/IgG1dull/CD38dull (G), and NIP binding/
IgG1high/CD381 (M) B cells were purified by flow cytometer from the pooled spleens of NP-CG-primed C57BL/6 mice (n 5 4) at day 60
postimmunization. Total RNAs were transcribed into cDNA using oligo dT and then the cDNAs were subjected to a PCR amplification of 22,
25, and 28 cycles to quantify the amount of indicated mRNA. No DNA was added to the PCR reaction (–) as a negative control. Each PCR
product was duplicated, separated by agarose gel electrophoresis, and analyzed by Southern blotting with specific probes (a). The average
signal intensity was standardized with that of b-actin at a 25 cycle, and the lowest value among the experimental group was arbitrarily
calculated as 31 (b). Each column represents the average amount from three independent experiments with the corresponding individual
values (circles).
(D) The kinetics of NIP binding GC (IgG1dull CD38dull, closed circles) B cells and memory (IgG1high CD381, open circles) B cells. Splenocytes
were obtained from NP-CG-primed C57BL/6 mice at the indicated time points. Dead cells and the (IgM, IgD, CD90, CD43, CD5) 1 cells were
excluded from the analysis by gating, and then NIP binding B cell subpopulations were enumerated by flow cytometer. Each circle represents
the actual number obtained for individual mice. Bars represent the average number for each group. A minimum of 1,000,000 events was
collected for each analysis.
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Figure 3. An Accumulation of Somatic Muta-
tions at GC B Cells and Memory B Cells
NIP binding GC B cells (IgG1dull/CD38dull) (A)
and memory B cells (IgG1high/CD381) (B) were
purified from the pooled spleens of NP-CG-
primed C57BL/6 mice (n $ 4 per each time
point), and the rearranged VH genes were am-
plified by two rounds of nested PCR. VH genes
encoded by V186.2 were dominant among
the recovered clones (.90%) and selected
for further analysis. Circles represent the
number of mutations in individual VH186.2
genes. Closed circles represent the number
of mutations in individual genes carrying a
Trp to Leu substitution at the position 33
(Leu33) and Tyr at position 99 (Tyr99). Trian-
gles represent the numbers of mutations in
individual VH186.2 genes bearing Gly at posi-
tion 99 (Trp33/Gly99 group). Complete sequence data are available from DDBJ/EMBL/GenBank under accession numbers AB043299-AB043361
(GC B cells), AB043225-AB043241, and AB043264-AB043298 (memory B cells).
ing with soluble NP-CG, the mice reconstituted with nucleotides at day 80 postimmunization. In contrast,
Figure 3B shows that mutations in the sequencedIgG1high/CD381 cells produced high-affinity anti-NP IgG1
antibodies in their immune sera (Figure 2A) and gener- VH186.2 clones from memory B cells were much less
frequent, and the overall mutation frequency in all of theated high-affinity NP-specific AFCs in their BM (Figure
2B), z20 times higher than the level found in the control VH186.2 genes sequenced remained constant at 1 in
60 to 70 nucleotides until 150 days postimmunization.mice, including those reconstituted with IgG1dull/CD38dull
cells. These results suggest that functional memory B These results seem compatible with the view that mem-
ory B cells are recruited from early generated GC B cellscells are enriched in NIP binding B cells with phenotype
IgG1high/CD381. and sustained for a long period (Schittek and Rajewsky,
1990; Gray et al., 1994).As shown in Figure 1Ae, NIP binding cells were also
detected in IgG12/CD381 B cells in the immunized mice, A quarter of the rearranged VH186.2 clones from the
memory B cells had no mutations. The majority of clonesalthough the number of cells was almost comparable to
the number detected in the nonimmunized mice (Figure carried tyrosine (Tyr99) or glycine (Gly99) in the V-D
boundary at an amino acid position 99 (64% on the1Ag). The fact that NIP binding/IgG12/CD381 cells in
the immunized mice did not reconstitute the secondary average, data not shown), that is utilized by most of
the antibodies selected by NP hapten in the primaryresponse with high-affinity anti-NP antibodies (data not
shown) led us to speculate that these cells may repre- response to T cell–dependent antigens (Cumano and
Rajewsky, 1985; Furukawa et al., 1999). However, thesent the naive B cells, which remained as a background
in the negatively selected splenocytes obtained using predominant usage of the rearranged VH186.2 gene and
Tyr99 or Gly99 was not detected in the primary responsea MACS system.
to a T cell–independent antigen (NP-ficoll), in which NP-
specific AFCs mostly utilize noncanonical VH genes inPersistent GC B Cells Accumulate a Large Number
of Somatic Mutations but Do Not Differentiate C57BL/6 mice, raising the possibility that the predomi-
nant usage of the rearranged VH186.2 gene is a charac-into Memory B Cells
In C57BL/6 mice, the anti-NP antibody response is domi- teristic feature of NP-specific B cells in a T cell–
dependent immune response (Maizels and Bothwell,nated by antibodies composed of a l1 light chain and
an H chain whose variable (V) region is encoded by the 1985). Consistently, PCR primer sets used in the present
study predominantly amplified the VH186.2 gene in puri-V segment, V186.2, rearranged to a D segment, DFL16.1
(Bothwell et al., 1982; Cumano and Rajewsky, 1985). To fied memory B cells (96%, data not shown) but not in
l11 B cells in the spleens of the nonimmunized micetrack the dynamics and developmental pathway of GC
B cells into memory cells at a clonal level, NIP binding (16%; Takahashi et al., 1999). We observed that the
rearranged VH186.2 gene was utilized in 10 out of 18 ofmemory B cells and GC B cells were purified from the
pooled spleens of immunized mice and subjected to the sequenced VH genes in NIP binding/IgG12/CD381
B cells, which were purified from the splenocytes ofPCR that preferentially amplifies the rearranged VH gene
encoded by the V186.2 or V3 subfamilies (Takahashi nonimmunized mice (data not shown; Figure 1Ad and
1Ag); however, the majority of these rearranged VH186.2et al., 1998). Amplified VDJ clones were sequenced to
identify the VH gene usage and any mutations present, genes encoded the heterogeneous amino acids at a
position 99, other than Tyr99 or Gly99 (9/10, 90%).and we observed that more than 90% of the recovered
IgH gene was encoded by the V186.2 gene segment Therefore, taken together with the observation that
memory phenotype B cells were highly enriched in the(data not shown).
As shown in Figure 3A, GC B cells continuously accu- splenocytes of the immunized mice by the sorting pro-
cess (Figure 1Ae and 1Ag), it seems unlikely that themulated somatic mutations in the rearranged VH186.2
genes over long periods following immunization, and the presence of nonmutated memory B cells represents
contamination by unstimulated B cells. These resultsoverall mutation frequency reached 1 in 14 sequenced
Germinal Center and Memory B Cells in lpr/lpr Mice
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Figure 4. The lpr Mutation Increases the
Number of Memory B Cells
The kinetics of GC B cells (A) and memory
B cells (B) in C57BL/6-lpr/lpr mice. Spleno-
cytes were recovered from NP-CG-primed
lpr/lpr mice (closed circles) and wild-type
control mice (open circles) at the indicated
time points, and NIP binding/B2201/IgG1dull/
CD38dull cells (A) and NIP binding/B2201/
IgG1high/CD381 cells (B) were enumerated by
flow cytometer. Each circle represents the
number obtained from individual mice. The
data from the lpr/lpr and control mice were
statistically evaluated by the Mann-Whitney
nonparametric test (two-tailed). The results
are shown as * (p 5 0.0159), ** (p 5 0.0043), ***
(p 5 0.0303). (C) NIP binding/IgG1high/CD381/
B2201 cells were purified from the pooled
spleens (n 5 6) of NP-CG-primed lpr/lpr mice
(closed circles) and wild-type control mice
(open circles) at day 60 postimmunization.
These cells were i.v. injected into CG-primed
mice at the indicated cell numbers plus 1 3
107 of splenocytes from naive mice. Anti-NP2
IgG1 BM AFCs were enumerated in recipient
mice at day 10 after boosting. Each circle
represents the number from individual recipi-
ent mice. (D) The expression of Bcl-2-related
mRNA in B cell subpopulations in the lpr/
lpr mice. IgD1B2201 cells (N), NIP binding/
B2201/IgG1dull/CD38dull cells (G), and NIP
binding/B2201/IgG1high/CD381 cells (M) were
purified from the pooled spleens of NP-CG-
primed C57BL/6-lpr/lpr mice (n 5 4) at day 60
postimmunization. The amount of indicated
mRNA was analyzed by semiquantitative
PCR as described in Figure 1C. Each column
represents the average amount from three
independent experiments with the corre-
sponding individual values (circles).
support the view that the memory B cell compartment cells are selected for antigen binding and a shorter CDR3
of nine amino acids or less in length and then later foris established by a considerable number of cells that
are selected in the immune response, at a time prior to affinity increasing mutations (McHeyzer-Williams et al.,
1993). As depicted in Table 1, analysis of the mutationalthe onset of somatic mutation (Gray et al., 1994).
pattern and CDR sequences of VH genes at the indicated
times raised the possibility that clonal selection in GCsClonal Selection in GCs Is Impaired in lpr/lpr Mice
Fas (CD95) is highly expressed on GC B cells and moder- may be impaired in the lpr/lpr mice. The ratio of replace-
ment to silent (R/S) mutations in CDR1 and CDR2 of theately expressed on AFCs and memory B cells (Liu et al.,
1995; Smith et al., 1995; Kimoto et al., 1997; Figure VH186.2 genes exceeded the value expected in random
mutagenesis in normal GC B cells at day 20 postimmuni-1C). Although GC B cells are highly susceptible to Fas-
mediated apoptosis in vitro (Liu et al., 1995), a previous zation (p 5 0.0468), suggesting that a fraction of the
replacement mutations was positively selected in theanalysis by tracing GC and memory B cells together in
lpr/lpr mice did not reveal the role of Fas in the NP- CDRs of the VH186.2 gene (Weiss and Rajewsky, 1992;
McHeyzer-Williams et al., 1993).specific B cell response (Smith et al., 1995). In this con-
text, we tracked the rate of formation and eventual size Particularly, a replacement mutation from tryptophan
(Trp33) to leucine (Leu33) was predominantly selectedof the NP-specific GC and memory B cell population
separately in C57BL/6-lpr/lpr mice after immunization in CDR1 at position 33 in the VH186.2 genes (the Leu33/
Tyr99 group) of normal GC B cells at day 20 postimmuni-with alum-precipitated NP-CG.
As shown in Figure 4A, NIP binding GC B cells (IgG1dull/ zation (14/17, 82.4%), accompanied by the selection of
a CDR3 of nine amino acids in length (12/14, 86%).CD38dull) emerged in the lpr/lpr and control mice with
similar kinetics, except for the frequency of cells at day The substitution from Trp33 to Leu33 has been shown
to result in increased affinity for NP (Cumano and Rajew-40 postimmunization, when the number of GC B cells
was greater in the lpr mice than that in the control mice sky, 1985; Allen et al., 1988). This possibility was sup-
ported by an affinity measurement of a large number of(p 5 0.0159), probably reflected by the higher proliferat-
ing activity found in the lpr mice than that found in the anti-NP mAbs established in the primary response in
C57BL/6 mice, indicating that antibodies carrying thecontrol mice (p 5 0.0105, Figure 5C).
It has been previously postulated that NP-specific B Leu33 substitution generally display about a 10 times
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Figure 5. An Accumulation of Somatic Muta-
tions in GC B Cells, Memory B Cells, and
Secondary BM AFCs from lpr/lpr Mice
NIP binding/IgG1dull/CD38dull/B2201 (A) and
NIP binding/IgG1high/CD381/B2201 (B) cells
were sorted from the pooled spleens of NP-
CG-primed lpr/lpr mice (n $ 4 per each time
point) and the rearranged VH genes were se-
quenced as described in Figure 3. Circles
represent the number of mutations in individ-
ual VH186.2 genes. Closed circles respresent
the number of mutations in the individual
genes carrying Leu33 and Tyr99 (Leu33/
Tyr99). Triangles represent the number of mu-
tations in individual Trp33/Gly99 group. Com-
plete sequence data are available from DDBJ/
EMBL/GenBank under accession numbers
AB043188-AB043224 (GC B cells), AB044808-
AB044823, and AB043139-AB043187 (mem-
ory B cells). (C) Proliferative activity of GC B
cells and memory B cells from the lpr/lpr and
control mice. Forty days after immunization,
the lpr/lpr mice (lpr/lpr) or wild-type control
mice (1/1) were i.p. injected with a single
shot of 1 mg of BrdU. Two hours later, the
NIP binding GC B cells (IgG1dull/CD38dull) and
memory B cells (IgG1high/CD381) were purified
from the pooled spleens (n $ 4) and stained
with anti-BrdU mAbs after fixation. The ratios
of BrdU-incorporated cells were determined
under confocal microscopy. Columns repre-
sent the average percentage of BrdU1 cells
from three independent experiments with the
corresponding individual values (open cir-
cles). The results were statistically evaluated
by the student’s t test. (D) Frequencies of somatic mutations in VH genes of l11 BM AFCs in the secondary anti-NP response. NIP binding
memory cells were purified from pooled spleens (n 5 4) of lpr/lpr mice (lpr/lpr) or control mice (1/1) at day 60 postimmunization. Some of
them (n 5 4) were challenged with 50 mg of soluble NP-CG, followed by purification of l11 CD138 1 (syndecan) cells from the pooled BMs
10 days later. The rearranged VH genes joined to Cg1 were amplified by two rounds of nested PCR. More than 95% of the rearranged VH
genes were encoded by V186.2 and selected for further analysis. Shown is the number of mutations in individual VH186.2 genes. Closed circles
represent the number of mutations in individual Leu33/Tyr99 group. Triangles represent the number of mutations in individual Trp33/Gly99
group. Frequencies of somatic mutations between lpr/lpr and 1/1 mice were statistically evaluated by the Mann-Whitney nonparametric tests
(two-tailed). Complete sequence data are available from DDBJ/EMBL/GenBank under accession numbers AB043362-AB043399 (AFCs),
AB043242-AB043263 (memory B cells).
higher affinity than those without the substitution (Furu- cells at day 20 postimmunization but increased during
the late primary response and became dominant at daykawa et al., 1999; M. Shimoda and G. Kelsoe, personal
communications). 80 postimmunization (p 5 0.0008). In contrast, the fre-
quency of the Trp33/Gly99 group remained the minorIn contrast, the frequency of the VH186.2 gene with
indications of antigen-driven selection was low in the fraction in the VH186.2 genes of the lpr GCs at day 60
postimmunization, supporting the idea that the matura-lpr GC at days 20 and 40 postimmunization (Table 1).
However, as the replacement mutations were positively tion pathways for the Trp33/Gly99 were skewed in the
lpr/lpr mice. Taken together, these results suggest thatselected in the CDRs of the VH186.2 gene (p 5 0.0483),
the Leu33/Tyr99 group with a CDR3 of nine amino acids the lpr defect affects clonal selection in GCs.
in length became dominant in the sequenced VH186.2
genes (9/12, 75%) at day 60 postimmunization (p 5 Expansion of the Memory Compartment in lpr/lpr
Mice at the Late Primary Response Stage0.0391). Thus, it appears that positive selection did work
in lpr GCs, but not as efficiently as it did in the control As shown in Figure 4B, the frequency of memory cells
with phenotype NIP binding/IgG1high/CD381/B2201 in-mice.
Over long periods after immunization, clonal complex- creased in the lpr/lpr mice about 4-fold above the level
found in the control mice from day 20 to day 40 afterity gradually decreased in a comparable manner in both
the normal and the lpr/lpr mice (Table 1). The antigenic immunization, whereas the size of the memory compart-
ment in the normal mice had already reached plateauselection at a later stage of the primary response ex-
pands antibodies carrying Trp33 and Gly99 (Trp33/ at that period. As shown in Figure 4C, NIP binding/
B2201/IgG1high/CD381 cells from lpr/lpr mice reconstitu-Gly99) with an accumulation of amino acid substitutions,
resulting in a 10 to 100 times higher affinity than those ted the secondary anti-NP antibody response in their
adopted hosts upon restimulation with soluble NP-CGcarrying the Leu33/Tyr99 (Furukawa et al., 1999). The
Trp33/Gly99 group was in the minority in normal GC B as efficiently as did the cells from the control mice at
Germinal Center and Memory B Cells in lpr/lpr Mice
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Table 1. Summary of B Cell Selection in GCsa
Days
Leu33/Tyr99 TRP33/Gly99 R/S Ratio
postimmunization %b p Valuec %b p Valuec CDR112d p Valuee FW1 –3f Clonalityg
1/1 day 8 ,7.7 (0/13) — ,7.7 (0/13) — .8.0h ND 1.8 0.77 (10/13)
day 20 82.4 (14/17) — 11.8 (2/17) — 18.3 0.0468 3.7 0.76 (13/17)
day 40 22.2 (4/18) 0.0006 38.9 (7/18) 0.1212 6.7 0.7386 1.2 0.72 (13/18)
day 80 ,6.7 (0/15) ,0.0001 73.3 (11/15) 0.0008 6.9 0.6360 2.2 0.53 (8/15)
lpr/lpr day 20 25.0 (3/12) — 8.3 (1/12) — 7.2 0.8211 0.7 0.92 (11/12)
day 40 30.8 (4/13) 1.0000 46.2 (6/13) 0.0730 7.0 0.6970 3.5 0.69 (9/13)
day 60 75.0 (9/12) 0.0391 16.7 (2/12) 1.000 12.6 0.0483 1.5 0.67 (8/12)
(5.6)i (3.1)i
a Data were based on the sequence analysis of VH186.2 genes from GC B cells in the lpr/lpr and control (1/1) mice, as depicted in Figures 3
and 5. b The % was calculated as 100 3 (number of positive VH genes/ number of VH186.2 genes sequenced). c The two-sided p value is
determined by Fisher’s exact test between the value at day 20 and at the indicated time point. d R/S ratio for CDR1 1 2 in all VH186.2 genes
sequenced. e The two-sided p value is determined by Fisher’s exact test between the R/S ratios at the indicated time point and that expected
in a model of random mutagenesis in CDR112. f R/S ratio for framework 11213 in all VH186.2 genes sequenced. g The ratio was calculated
by (number of VH genes with different unique CDR3 nucleotide sequence / number of VH186.2 sequenced). h The value cannot be calculated
because there were no silent mutations in CDR112. i Expected R/S ratio of the VH186.2 genes with random mutagenesis.
the various transfer amounts, indicating a similar fre- tion (2.4 6 1.6% and 1.5 6 0.1% in untreated and treated
mice, respectively; p 5 0.3859). Thus, memory B cellsquency of functional memory B cells in NIP binding/
IgG1high/CD381/B2201 cells between the lpr/lpr and con- appeared to proliferate, but much less significantly than
did the GC B cells.trol mice. As shown in Figures 4D and 1C, semiquantita-
tive RT-PCR analysis indicated that the level of Bcl-2, A 2 hr BrdU pulse labels those cells that have entered
the S phase and those that will enter the S phase withinBcl-xL, and Bcl-6 expression was comparable in mem-
ory phenotype B cells in the lpr/lpr and the control mice. 2 hr labeling period. Considering that an S phase period
generally takes 6–8 hr in the cell cycle, the results inThus, memory B cells in the lpr/lpr mice were indistin-
guishable from those in the control mice, in terms of Figure 5C imply that normal and lpr memory B cells
proliferate every 14–17 and 8–10 days, respectively.morphology (Figures 1Bb and 1Be), the level of Bcl-2,
Bcl-xL, and Bcl-6, the level of CD38 and IgG1 (Figures Given that somatic mutations arise at a rate of 1023/
base pair/generation (McKean et al., 1984), it is conceiv-1Ae and 1Af), and the capability to differentiate into
AFCs. able that normal and lpr memory B cells may accumulate
1.9 and 3.3 mutations at the maximum, respectively,
from day 20 to day 100 postimmunization. Alternatively,Memory B Cells Heavily Accumulate Somatic
Mutations in lpr/lpr Mice the results in Figure 5C imply that 6%–7% and 10%–13%
of memory cells are cycling per day in the control miceAs shown in Figure 5A, GC B cells in the lpr/lpr mice
accumulated mutations at a rate comparable to that of and the lpr/lpr mice, respectively. These calculations
supported the notion that the high rate of somatic muta-normal B cells (Figure 3A). Figure 5B shows that memory
B cells in the lpr/lpr mice accumulated an average of tions accumulated in the lpr memory compartment, at
least from day 20 to day 60 postimmunization, is not1.8 mutations per rearranged VH186.2 gene at day 20
postimmunization; however, to our surprise, the majority merely a consequence of the proliferation of memory
cells.of the lpr memory cells heavily accumulated mutations
at day 40 postimmunization, with an average of 9.2 mu-
tations per rearranged VH gene. The average number of Disruption of Persistent GC Reaction in lpr/lpr
Mice Normalizes the Size of the Memorymutations per rearranged VH186.2 gene increased from
9.2 at day 40 to 14.2 at day 60 and finally reached to B Cell Compartment through the Loss
of Heavily Mutated Cells16.6 at day 100 postimmunization.
To examine whether the high rate of mutations accu- Successive administration of hamster anti-mouse CD40-
ligand mAb (MR1) leads to a complete disruption ofmulated in the lpr memory B cells might be due to an
accelerated proliferative activity, we analyzed the cell GCs, without affecting preformed long-lived AFCs (Han
et al., 1995; Takahashi et al., 1998). As shown in Figurecycle in the GC and memory B cells by BrdU-incorpora-
tion at day 40 postimmunization (Figure 5C). As pre- 6, to elucidate the role of persistent GC reaction in the
formation of the memory B cell compartment, we admin-viously reported (Schittek and Rajewsky, 1990; Kimoto
et al., 1997), a large number of GC B cells incorporated istered MR1 antibody or normal hamster IgG into mice
at days 20, 22, and 24 after the primary immunizationBrdU over a 2 hr pulse in both the lpr/lpr and control
mice, whereas the average number of labeled cells was with alum-precipitated NP-CG. As expected, the anti-
body treatment caused more than a 30-fold reduction2.4% and 4.2% in the normal and the lpr memory B
cell compartment, respectively (Figure 5C). Successive in the number of GC B cells in both the lpr/lpr (p 5
0.0009) and control mice (p 5 0.0194) at 16 days afteradministration of anti-CD40 ligand mAb abrogated the
GC reaction (Han et al., 1995; Figure 6), but it did not manipulation (Figure 6A). Administration of anti-CD40
ligand mAb resulted in a significant suppression in thesignificantly reduce the frequency of memory cells la-
beled with BrdU in normal mice at day 40 postimmuniza- number of memory B cells in the lpr/lpr mice (p 5
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of the mice as described previously (Takahashi et al.,
1998). The NP-specific BM AFC in each group of mice
showed a more than 9-fold increase in numbers after the
secondary challenge, suggesting that about 90% of the
sorted cells represented newly generated AFCs after
the secondary challenge. The mutation frequency in the
lpr AFC was significantly higher than in the control AFC
(p 5 0.001), and the average number of mutations per
rearranged VH genes was 15.4. These results suggest
that heavily mutated memory B cells in lpr/lpr mice dif-
ferentiate into plasma cells in the secondary immune
response.
It appears that NP-specific secondary AFCs utilize
Leu33/Tyr99 at a frequency higher than that of their
precursors (memory B cells) in both the lpr/lpr and con-
trol mice, respectively, but the differences were not sta-Figure 6. Administration of Anti-CD40 Ligand mAb Suppresses the
tistically significant (data not shown). The fraction ofNumber of Memory B Cells and the Frequency of Mutations in Their
cells utilizing Trp33/Gly99 remained constant in the con-VH Genes in lpr/lpr Mice
trol mice during the progression. In the lpr/lpr mice,(A) At days 20, 22, and 24 after immunization with NP-CG, both the
lpr/lpr and control (1/1) mice were treated with anti-CD40-ligand however, the frequency of Trp33/Gly99 in secondary
mAb (MR1; open circles) or control hamster IgG antibody (HIgG; AFCs was 5 times below the level of their precursors
closed circles) and then sacrificed at day 40 after primary immuniza- (p 5 0.0142), led to the idea that the Trp33/Gly99 group
tion. The numbers of NIP binding GC B cells (IgG1dull/CD38dull) and
in the lpr memory compartment was not efficiently se-memory B cells (IgG1high/CD381) were enumerated by flow cyto-
lected for the progression from memory cells to themeter. Circles represent the number of individual mice. The number
secondary AFCs.of cells between MR1- and HIgG-treated mice was statistically eval-
uated by the student’s t test. The results were shown as * (p 5
0.0194), ** (p 5 0.0009), *** (p 5 0.0004). Discussion
(B) NIP binding/B2201/IgG1high/CD381 cells (memory) were purified
from the pooled spleens of treated mice (n 5 6) and the nucleotide
Previous reports have indicated that two clonotypessequences of the rearranged VH genes were determined. Circles
of high-affinity antibodies are selected in the primaryrepresent the number of mutations in individual VH186.2 genes.
Closed circles represent the number of mutations in individual response against the NP-hapten. One encoded by the
Leu33/Tyr99 group. Triangles represent the number of mutations in VH186.2 genes carrying the Trp to Leu mutation at posi-
individual Trp33/Gly99 group. Frequencies of somatic mutations tion 33 along with Tyr at position 99 (Leu33/Tyr99)
between MR1- and HIgG-treated mice were statistically evaluated
emerges in the early primary response and is then sub-by the Mann-Whitney nonparametric tests (two-tailed). Complete
stituted by the other utilizing the heavily mutated VH186.2sequence data are available from DDBJ/EMBL/GenBank under ac-
genes with Trp33/Gly99 in the later primary responsecession numbers AB043400-AB043444.
(Cumano and Rajewsky, 1985; Allen et al., 1988; Furu-
kawa et al., 1999). The present study suggests that GCs
are the primary sites where time-dependent and differ-0.0004), but not in the control mice (p 5 0.0843). Further-
more, as shown in Figure 6B, the antibody treatment ential selection for high-affinity B cells bearing Leu33/
Tyr99 and Trp33/Gly99 antibodies takes place. Thereduced the average number of mutations per re-
arranged VH gene in the lpr memory B cells, from 7.7 to Leu33/Tyr99 group became dominant in the VH186.2
genes of GC B cells in control mice at day 20 postimmu-2.2 (p 5 0.0006), which is equivalent to the average
number of mutations in the control memory B cells. nization, accompanied by a predominant selection of a
CDR3 of nine amino acids in length, whereas the heavilyThe antibody treatment slightly increased the number
of mutations in normal memory cells, but the difference mutated Trp33/Gly99 group dominated over the Leu33/
Tyr99 group at day 80 postimmunization (Figure 3A;is not statistically significant (p 5 0.3502). Taken to-
gether, these results strongly suggest that the lpr mem- Table 1). However, the lpr defect impaired the prompt
selection of replacement mutations in both CDR1 andory compartment is recruited by a large number of pre-
cursors newly generated in the GCs from day 20 onward 2 in the VH186.2 genes of GC B cells and the predominant
enrichment of the Leu33/Tyr99 group with a CDR3 ofafter immunization, whereas the normal memory com-
partment is mostly established up to day 20 postimmuni- nine amino acids in length and, probably, the following
selection for the Trp33/Gly99 group in GCs (Figure 5A;zation.
Table 1).
Fas-mediated apoptosis is blocked by signalingHeavily Mutated Memory B Cells Contribute
to the Secondary Immune Response through the BCR, although the extent of this effect de-
pends on the level of stimulation (Rothstein et al., 1995;As shown in Figure 5D, to investigate whether heavily
mutated memory B cells differentiate into AFC upon Foote et al., 1998). Therefore, it is conceivable that the
lpr defect may affect the negative selection of B cells,restimulation with the antigen as conventional memory
B cells (Arpin et al., 1998), lpr/lpr and control mice were resulting in an accumulation of a large number of low-
affinity B cells within the GCs. Indeed, the lpr/lpr miceboosted with soluble NP-CG 60 days after the primary
immunization with the same antigen in alum. Ten days sustained a number of GC B cells 3- to 4-fold above the
level of the control mice at day 40 postimmunization.later, the l11 AFC population was purified from the BM
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The frequency of proliferating cells was higher in lpr frequency of cycling cells, is insufficient to drive the
high rate of somatic mutations present in the lpr memoryGCs than in control GCs at that period, raising the idea
that low-affinity B cells may also proliferate and incorpo- compartment from day 20 to day 60 postimmunization,
leading to the model in which the lpr memory B cellrate somatic mutations. An accumulation of large num-
bers of low-affinity B cells may interfere with the enrich- compartment is continuously recruited by newly gener-
ated precursors over long periods after immunization.ment of high-affinity B cells utilizing Leu33/Tyr99 and
Trp33/Gly99 in the early and late immune response, re- In this context, however, it remains to be elucidated
whether a low rate of accumulation of somatic mutationsspectively (Figure 5A; Table 1).
It has been postulated that somatic mutation of the from 14.2 at day 60 to 16.6 at day 100 postimmunization
could be largely associated with the proliferation of lprGC B cells substantially stops within 3 weeks postimmu-
nization (Smith et al., 1997). However, the present study memory B cells. Taken together, these results support
the notion that the Fas/FasL interaction controls theclearly indicates that NP-specific GC B cells progres-
sively accumulated somatic mutations over 2 months differentiation pathway into memory B cells and pre-
vents a retention of heavily mutated B cells in the mem-after immunization, resulting in an average of 22 muta-
tions per rearranged VH186.2 gene at day 80 postimmu- ory compartment.
The important question as to how the lpr defect accel-nization (range 15228). This implies that NP-specific GC
B cells may continuously proliferate and accumulate erates the recruitment of precursors from late GCs into
the memory pool remains to be answered. We have notmutations upon stimulation with persisting antigen
within the GCs. In contrast, NP-specific memory B cells found any phenotypic difference between the early and
late GC B cells, except for the level of sIgs, which isretained a low frequency of mutations over long periods
after immunization, with an average of only three to lower in the late GC B cells than in the early GC B cells
(data not shown). B cell activation mediated by BCRfour mutations per VH gene sequenced even at day 150
postimmunization (range 1–13/mutated gene). A quarter depends on the antibody avidity, associated with the num-
ber and affinity of sIgs (Batista and Neuberger, 1998).of the memory B cells did not accumulate somatic muta-
tions at all and were probably generated earlier than the Assuming that Fas-mediated apoptosis is blocked by sig-
nals through the BCR and depends on signal strengthonset of the somatic mutations (Gray et al., 1994). These
results seem compatible with the model that the memory that is comparable between early and late GC B cells,
it is conceivable that downregulation of sIg expressionB cell compartment is established by precursors from
early GCs formed within 3 weeks after immunization, as in late GCs results in an increased affinity-threshold in
antigen-driven positive and negative selection. In agree-previously proposed (Schittek and Rajewsky, 1990).
Administration of anti-CD40 ligand mAb at day 20–24 ment with this possibility, antibodies bearing Trp33/
Gly99, selected at the late primary immune response,after immunization abrogated the subsequent GC reac-
tion, but the number of memory B cells remained largely have an affinity 10- to 100-times higher than that of those
with Leu33/Tyr99 (Furukawa et al., 1999). However, theunaffected, supporting the view that memory compart-
ments are essentially long lasting once established lpr defect may affect the affinity-dependent negative
selection, probably allowing survival of low-affinity B(Schittek and Rajewsky, 1990). Heavily mutated VH186.2
genes were present at low frequencies in late memory cells and their subsequent differentiation into memory
cells.compartments of normal mice, supporting the view that
small numbers of cells generated in the late GCs may BCR stimulation prevents Fas-mediated apoptosis,
probably by activating antiapoptotic and prosurvivalenter the memory compartment. However, whether a
minor population of memory B cells reenters the somatic molecules, including Bcl-xL (Schneider et al., 1997). Bcl-
xL partially blocks Fas-mediated apoptosis (Schneidermutation pathway remains to be elucidated (Berek et
al., 1987). et al., 1997), and overexpression of Bcl-xL extends B
cell survival in GCs and generation of long-lived IgG11NP-specific memory B cells in the lpr/lpr mice ex-
panded until day 40 post immunization and reached AFCs with heavily accumulated mutations in their VH
genes (Takahashi et al., 1999). Overexpression of Bcl-2their maximum with the frequent appearance of heavily
mutated VH186.2 genes, greater than the level of that also causes a prominent expansion of the memory com-
partment; however, in contrast to the lpr/lpr mice, bcl-found in the control mice. Disruption of the GC reaction
later than day 20 post immunization by anti-CD40 ligand 2-transgenic mice accumulated memory B cells bearing
less mutated VH genes with a lower degree of affinitymAb treatment caused a significant reduction in both
the number of memory B cells and their mutation fre- maturation than those found in control mice (Smith et al.,
2000). Regardless of the different effects on the kinetics,quencies. These results suggest that the lpr defect ac-
celerates the recruitment of newly generated precursors both the lpr defect and the overexpression of Bcl-2 en-
hances the recruitment of GC B cells into the memoryfrom the late GCs.
There was no further increase in the number of lpr compartment, which is compatible with the idea that
prosurvival or antiapoptotic activity influences the pro-memory cells later than day 40 postimmunization,
whereas the overall mutation frequencies of the lpr cess of differentiation into memory cells.
The lpr defect causes spontaneous development ofmemory cells were significantly increased from day 40
to day 100 postimmunization, from an average of 9.2 to an autoimmune disorder (Cohen and Eisenberg, 1991).
The double negative (DN) T cells represent a major cell16.6 mutations per VH genes, respectively. Based on
the results of BrdU-incorporation, we calculated that type in the peripheral lymphoid compartments of dis-
eased lpr mice (Cohen and Eisenberg, 1991; Jacobsonlpr memory B cells may proliferate every 8–10 days,
or alternatively, that 10%–13% of the lpr memory cells et al., 1995). Their progressive accumulation in the white
pulp cord of the spleen causes splenomegaly and dis-proliferate per day. However, the proliferation rate, or
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memory cells in the spleen, the cells were blocked with anti-FcgRII/rupts the anatomical organization, which may affect the
III and incubated with biotinylated mAbs against IgM, IgD, CD5, CD90,ability of both T cells and B cells to collaborate efficiently
and CD43, followed by incubation with streptavidin-coated mi-to mount an immune response to exogenous antigens
crobeads (Miltenyi Biotec, Gladbach, Germany). Thereafter, the cells
(Jacobson et al., 1995). This distortion of the splenic were separated on a MACS column (Miltenyi Biotec), and the nega-
architecture could also affect compartmentalization of tively selected cells were then stained with anti-CD38APC, anti-
B220TX, NIP-BSAPE, and IgG1FITC, followed by incubation with strep-the memory B cells that migrate into the marginal zone
tavidineTC and 7-AAD. To sort BM AFCs, cells were incubated withof the spleen after selection (Liu et al., 1988; Dunn-
biotinylated mAbs against IgM, IgD, CD5, Mac-1, Gr-1, and CD90,Walters et al., 1995). Whether or not the accumulation
followed by negative selection with use of a MACS system. Thereaf-of abnormal DN T cells and other pathogenic effects
ter, cells were stained with FITC-labeled anti-l1 (PharMingen), PE-
affect the selection and survival of memory B cells in conjugated anti-CD138 (PharMingen), anti-CD38APC and anti-B220TX
the lpr/lpr mice remains to be elucidated. mAbs and with streptavidineTC and 7-AAD.
Cells were analyzed and sorted with a FACS Vantage (BectonIn summary, the present study demonstrated that Fas
Dickinson, Mountain View, CA) equipped with appropriate filters forplays an important role in clonal selection within GCs
five-color analysis in a dual argon laser (488 nm)/dye laser (599 nm)and in the establishment of the B cell repertoire in the
system. TC is excited by the dye laser as well as the argon laser,memory compartment. At present, we do not know if
resulting in the detection of TC fluorescence across two channels
Fas is also involved in the regulation of CD431/B220dull (FL3 and FL4). For all experiments in this paper, only cells detected
memory B cells, which expand in the secondary immune as TC2 7-AAD2 cells in FL3 were gated for further analysis, thereby
avoiding the leak of TC fluorescence into the FL4 channel. At leastresponse (McHeyzer-Williams et al., 2000). The accumu-
one million total events were collected for each file and then ana-lation of somatic mutations results in a change in anti-
lyzed using CELL Quest software (Beckton Dickinson).body affinity for the antigen, but it may sometimes cause
a change in antibody specificity associated with the
Giemsa Staininggeneration of autoreactivity. However, Fas controls the
Sorted cells (1–3 3 104) were mounted on a glass slide (APS coated;
establishment of the memory pool through the recruit- Matsunami Glass IND. Ltd., Tokyo) by Cytospin (Shandon Ltd., Lon-
ment of precursors generated in the early immune re- don, GB) and fixed with 70% Methanol for 20 min, followed by
incubation with Giemsa staining solution (Muto Pure Chemical Co.sponse, which may greatly reduce the incidence of auto-
Ltd., Tokyo) diluted at 1:20 with distilled water.antibody generation in the secondary immune response.
Fas is also involved in the establishment of the preim-
Semiquantitative RT-PCRmune repertoire by exclusion of autoreactive B cells that
Total RNA was extracted from sorted, Trizol-solublized cells ac-
have been anergized by binding to soluble forms of cording to the manufacturer’s protocol (Gibco BRL, Gaithersburg,
autoantigens (Rathmell et al., 1995). In addition, it has MD). First-strand cDNA was synthesized from total RNA using oligo-
been recently reported that Fas also plays a role in d(T) primer and a Superscript Kit (Gibco BRL). The cDNAs were
amplified by PCR using the following conditions: 22, 25, and 28regulation of autoreactive B cells that are able to expand
cycles of 30 s at 948C, 20s at 588C, and 60 s at 728C. Primers usedand differentiate into AFCs upon antigen stimulation
for PCR were bcl-2 sense 59 TCGCTACCGTCGTGACTTC and bcl-2(Wang and Schlomchik, 1999). Thus, Fas serves as a
antisense 59 AAACAGAG-GTCGCATGCTG; bcl-xL sense 59 TGC
key regulator that excludes deleterious populations from GTGGAAAGCGTAGACAAGG and bcl-xl antisense 59 AGTGGATGG-
the long-lived pre- and postimmune repertoire. TCAGTGTCTGGTCAC; bcl-6 sense 59 AGCAAGAACGCCTGCA
TCCTTC and bcl-6 antisense 59 CATCTCTGTATGCTGTGGGGA;
Fas sense 59 AGAGTTCATACTCAAGGTAC and Fas antisense 59Experimental Procedures
CTTGGATGCTGTCATGCATG. The amount of b-actin was simulta-
neously quantified for normalization of templates using the followingMice and Immunizations
primers: b-actin sense 59 GTGGGAATTCGTCAGAAGGACTCCTATFemale C57BL/6 and C57BL/6-lpr/lpr mice were purchased from
GTG and b-actin antisense 59 GAAGTCTAGAGCAACATAGCACAGSLC Inc. (Hamamatsu, Japan) and maintained in a specific-pathogen
CTTCTC. The PCR products were separated by a 1.5% agarose gelfree condition. Six-week-old mice were primed intraperitoneally with
electrophoresis, transferred onto nylon membranes, and hybridized100 mg of NP12-CG conjugate precipitated in alum. Anti-CD154 anti-
with 32p-labeled probes. The signal intensities of the PCR productsbody (MR1, kindly provided by Dr. G. Kelsoe, Duke University) or
were then quantitated with an Image Analyzer (BAS2000; Fuji Photonormal hamster IgG (Pierce Chemical Co., Rockford, IL) was admin-
Film, Tokyo, Japan).istered on days 20, 22, and 24 after primary immunization, with 300
mg of antibody per each injection. Fifty micrograms of soluble NP12-
CG was administered intravenously for the secondary challenge. Adoptive Transfer Experiment
NIP binding cells with phenotype of IgG1high/CD381 and IgG1dull/
CD38dull were purified by FACS sorting. These sorted cells (2 3 103)Flow Cytometry and Cell Sorting
were mixed with 1 3 107 splenocytes from naive C57BL/6 mice andSingle cell suspensions were prepared from spleens and BMs, and
injected intravenously into C57BL/6 mice, which were immunizedthen the red blood cells were depleted by incubation in 0.83% NH4Cl.
intraperitoneally with 100 mg of CG in alum 30 days before. OneCells were blocked with 20 mg/ml of anti-FcgRII/III (2.4G2; Phar-
hour later, the mice were boosted intravenously with 50 mg of solubleMingen, San Diego, CA) and incubated with a mixture of biotinylated
NP-CG, and sera and BM cells were collected from individual miceantibodies against IgM, CD90, CD5 CD43 (PharMingen), and IgD
10 days later.(Southern Biotechnologies, Associates, Birmingham, AL) to exclude
naive B cells, B-1 cells, AFCs, and T cells from the analysis. After
ELISA and ELISPOT Assayswashing, the cells were incubated for 30 min with a mixture of
High-affinity IgG1 antibodies and BM AFCs specific for NP haptenantibodies [FITC-labeled anti-IgG1 (IgG1FITC; PharMingen), PE-con-
were detected by ELISA and ELISPOT, respectively, by using lowjugated NIP26-BSA (NIP-BSAPE), allophycocyanin (APC)-conjugated
coupling ratios of NP-BSA (NP2-BSA) as previously described (Taka-anti-CD38 (anti-CD38APC, kindly provided by Dr. K. Miyake, Saga
hashi et al., 1998).Medical School), Texas Red (Tx)-labeled anti-B220 (anti-B220TX)],
and with Tricolor (TC)-conjugated streptavidine (streptavidineTC,
Caltag Laboratories, Burlingame, CA) and 7-amino-actinomycin D Estimation of Proliferative Activity by BrdU-Labeling
Forty days after immunization, C57BL/6 and C57BL/6-lpr/lpr mice(7-AAD) which is a G-C base specific DNA intercalator that can be
used for dead cell discrimination (Schmid et al., 1992). To sort GC and were intraperitoneally injected with 1.0 mg BrdU (Sigma Chemical
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Co.) 2 hr before sacrifice. Sorted GC and memory B cells were then after treatment with interleukin 4 but not after treatment with specific
antigen unless a surface immunoglobulin threshold is exceeded. J.mounted on a glass slide, fixed with 1% paraformaldehyde, and
stained with FITC-labeled anti-BrdU mAb (Beckton Dickinson) as Exp. Med. 187, 847–853.
previously described (Kimoto et al., 1997). Proliferation indices were Furukawa, K., Akasako-Furukawa, A., Shirai, H., Nakamura, H., and
determined by confocal microscopic inspection of .80 B2201 cells Azuma, T. (1999). Junctional amino acids determine the maturation
as the fraction (%) of B2201 cells that exhibited nuclear BrdU incor- pathway of an antibody. Immunity 11, 329–338.
poration.
Gray, D., Dullforce, P., and Jainandunsing, S. (1994). Memory B cell
development but not germinal center formation is impaired by in
Sequence Analysis of VH Genes vivo blockade of CD40-CD40 ligand interaction. J. Exp. Med. 180,
NIP binding cells with a phenotype of IgG1highCD381 and
141–155.
IgG1dullCD38dull were directly sorted into 500 ml of proteinase K solu-
Gulley, M.L., Ogata, L.C., Thorson, J.A., Dailey, M.O., and Kemp,tion (400 mg/ml proteinase K in 1:5-diluted PBS) and incubated
J.D. (1988). Identification of a murine pan-T cell antigen which isovernight at 378C. The crude lysate was subjected to two rounds
also expressed during the terminal phases of B cell differentiation.of PCR (Takahashi et al., 1998). BM AFCs were directly sorted into
J. Immunol. 140, 3751–3757.Trizol containing 50 mg/ml tRNA (Roche Diagnostics, Mannheim,
Germany), and VH gene cDNAs were amplified by PCR as previously Han, S., Hathcock, K., Zheng, B., Kelpler, T.B., Hodes, R., and
described (Takahashi et al., 1998). The nucleotide sequence of the Kelsoe, G. (1995). Cellular interaction in germinal centers. Roles of
cloned VH genes was determined by automated sequencing using CD40 ligand and B7-2 in established germinal centers. J. Immunol.
ABI PRISM 377 DNA sequencer (PE Biosystems, Foster City, CA). 155, 556–567.
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